Our analysis of the DepMap data shows that MRAS knockout is well tolerated in cancer cell lines that are strongly dependent on SHOC2 for survival, consistent with the hypothesis that H/K/NRAS may substitute for MRAS in certain contexts. The gene discussed is SHOC2; the disease is cancer.